Ma et al. reported that SNHG5 contributes to proliferation and inhibits the apoptosis of bladder cancer cells by downregulating p27 and caspase-3 and caspase-9 and upregulating CDK2 expression [32]. Here, CASP9 is linked to urinary bladder carcinoma.